TabCAT Brain Health Assessment in Primary Care

NARecruitingINTERVENTIONAL
Enrollment

180,000

Participants

Timeline

Start Date

July 27, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Mild Cognitive ImpairmentDementia
Interventions
OTHER

TabCAT Brain Health Assessment Clinical Pathway

Primary care providers concerned that their patients are exhibiting signs of cognitive decline will refer them to clinical associates who will then perform the TabCAT-BHA tablet-based test. The TabCAT-BHA paradigm comprises 7-10 minutes of tablet-based testing and an optional 3-minute self-administered informant survey captures behavioral symptoms and change from baseline. The results are available to the PCP in the EMR along with turnkey guidance to evaluate for reversible causes, identify and involve a care partner, make and disclose diagnosis, provide community and educational resources, and make medical referrals as appropriate. Nursing support is available to support the PCP in making the diagnosis and to consult to the family via telephone post-diagnosis to address immediate care needs.

Trial Locations (1)

91101

RECRUITING

Kaiser Permanente Southern California Department of Research & Evaluation, Pasadena

All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of California, San Francisco

OTHER